Venture capital firm

Hikma Ventures

The venture capital arm of Hikma Pharmaceuticals, investing in digital health and life sciences companies worldwide

Visit Website Get introducedRequest an introduction Write a Review

TrustList summary

Hikma Ventures is the venture capital arm of Hikma Pharmaceuticals, established in 2015 to broaden the pharmaceutical group's offerings and pursue opportunities in digital health and life sciences. It invests in companies where it believes its expertise and global presence can accelerate revenue growth and help differentiate Hikma's products, working with disruptive technologies and companies it says have a diverse leadership team. Its focus areas include drug delivery, digital therapeutics, clinical trial work, respiratory and central nervous system treatment, and oncology, along with select autoimmune and long-term conditions including type II diabetes and hypertension, and areas addressing overdose and abuse. While stage-agnostic, the firm says it prefers Series A rounds and beyond, is willing to lead or co-lead deals, and takes a long-term view of its portfolio companies.

Summary written by TrustList from the business's own published information, Sep 2026.

Categories & features

Rankings

Hikma Ventures is ranked on 1 TrustList ranking at #43.

Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Hikma Ventures has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.

Venture capital firm · 1 ranking

#43of 79
Biotech investors
It is one of 11 here listing series a.
Of the top 65 here, 22 also cover healthtech and 17 also cover science; 14 also work in Boston and 13 also work in San Francisco.
Behind Heuristic Capital Partners, ahead of incTANK Ventures.

As of 2026-10-31. Organic ranks only; sponsored placements are never ranks. How TrustList ranks